text
"['\n1. 요약재무정보\n \xa0본 요약연결재무정보 및 요약재무정보는 한국채택국제회계기준에 따라 작성되었으며, 제20기 1분기 요약연결재무정보 및 요약재무정보는 외부감사인의 감사(또는 검토)를 받지 않은 자료입니다\n(1) 요약 연결재무정보 \n(단위:천원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0목\n제20기 1분기\n제19기(2018년)\n제18기(2017년)\n[유동자산]\n41,056,977\n41,734,769\n28,022,224\nㆍ매출채권및기타채권\n10,582,282\n8,225,764\n3,724,634\nㆍ재고자산\n3,902,081\n3,213,944\n8,038,867\nㆍ기타 유동자산\n26,572,614\n30,295,061\n16,258,723\n[비유동자산]\n74,783,186\n65,372,475\n21,420,296\nㆍ장기매출채권 및 기타채권\n5,601\n122,374\n122,008\nㆍ유형자산\n3,345,919\n3,495,560\n13,824,214\nㆍ기타의 비유동자산\n71,431,666\n61,754,541\n7,474,074\n자산 \xa0총계\n115,840,163\n107,107,244\n49,442,520\n[유동부채]\n38,875,360\n29,169,409\n17,760,320\n[비유동부채]\n9,676,690\n4,690,185\n1,339,983\n부채 \xa0총계\n48,552,050\n33,859,594\n19,100,303\n[납입자본]\n22,274,896\n22,274,896\n15,110,923\n[기타자본구성요소]\n44,539,257\n152,608,102\n136,709,521\n[결손금]\n(1,634,770)\n(107,381,159)\n(121,478,227)\n[비지배지분]\n2,108,729\n5,745,811\n-\n자본 \xa0총계\n67,288,112\n73,247,650\n30,342,217\n종속기업 등 투자주식 평가방법\n지분법\n지분법\n지분법\n2019.01.01~03.31\n2018.01.01-12.31\n2017.01.01~12.31\n매출액\n16,394,367\n47,375,134\n26,832,432\n계속영업이익(손실)\n492,284\n(8,756,238)\n(15,937,902)\n계속영업당기순이익(손실)\n(727,785)\n(14,015,782)\n(34,710,537)\n중단영업당기순이익(손실)\n-\n-\n(3,228,841)\n당기순이익(손실)\n(727,785)\n(14,015,782)\n(37,939,378)\n당기총포괄손익(손실)\n(720,468)\n(14,125,465)\n(37,925,181)\n지배기업소유주지분\n(575,385)\n(13,630,959)\n(37,925,181)\n비지배기업소유주지분\n(145,083)\n(494,506)\n-\n계속영업기본주당이익(손실)\n(13)\n(307)\n(2,261)\n중단영업기본주당이익(손실)\n-\n-\n(210)\n계속영업희석주당이익(손실)\n(13)\n(307)\n(2,261)\n중단영업희석주당이익(손실)\n-\n-\n(210)\n연결에 포함된 회사수(개)\n7\n5\n1\n연결대상회사는 다음과 같습니다.\n연도\n제20기 1분기(2019년)\n제19기(2018년)\n제18기(2017년)\n회사명\n(주)모제림(주)넥스트매치(주)엔씨엘바이오(주)메타랩스코스메틱(주)모릭랩스(주)메타약품METALABS HONGKONG LIMITED\n(주)모제림(주)넥스트매치(주)엔씨엘바이오(주)메타랩스코스메틱(주)모릭랩스\nACREX CHINA INC.\n(2) 요약 별도재무정보 \n(단위:천원)\n과 \xa0 \xa0 \xa0 \xa0 \xa0목\n제20기 1분기\n제19기(2018년)\n제18기(2017년)\n[유동자산]\n28,019,970\n26,774,402\n25,071,711\nㆍ매출채권및기타채권\n3,191,731\n2,074,177\n3,937,575\nㆍ재고자산\n2,612,719\n1,461,090\n8,038,867\nㆍ기타 유동자산\n22,215,520\n23,239,135\n13,095,269\n[비유동자산]\n79,613,438\n67,574,337\n21,420,296\nㆍ장기매출채권 및 기타채권\n5,601\n112,220\n122,008\nㆍ유형자산\n1,746,079\n1,118,336\n13,824,214\nㆍ무형자산\n17,524,306\n2,098,965\n33,973\nㆍ기타의 비유동자산\n60,337,452\n64,244,816\n7,440,101\n자산 \xa0총계\n107,633,407\n94,348,739\n46,492,007\n[유동부채]\n33,312,607\n24,605,922\n14,583,735\n[비유동부채]\n5,646,593\n473,222\n1,339,983\n부채 \xa0총계\n38,959,200\n25,079,144\n15,923,718\n[납입자본]\n22,274,896\n22,274,896\n15,110,923\n[기타자본구성요소]\n47,262,718\n152,737,297\n137,187,580\n[결손금]\n(863,406)\n(105,742,598)\n(121,730,213)\n자본 \xa0총계\n68,674,208\n69,269,595\n30,568,289\n종속ㆍ관계ㆍ공동기업\n원가법\n원가법\n원가법\n투자주식의 평가방법\n2019.01.01-03.31\n2018.01.01-12.31\n2017.01.01~12.31\n매출액\n5,802,277\n18,522,860\n27,205,729\n계속영업이익(손실)\n(650,091)\n(11,991,186)\n(15,564,604)\n계속영업당기순이익(손실)\n(1,449,899)\n(14,211,574)\n(34,788,494)\n중단영업당기순이익(손실)\n-\n2,580,846\n-\n당기순이익(손실)\n(1,449,899)\n(11,630,728)\n(34,788,494)\n당기총포괄손익(손실)\n(1,449,899)\n(12,218,471)\n(34,774,297)\n계속영업기본주당이익(손실)\n(33)\n(322)\n(2,266)\n중단영업기본주당이익(손실)\n-\n59\n-\n계속영업희석주당이익(손실)\n(33)\n(322)\n(2,266)\n중단영업희석주당이익(손실)\n-\n59\n-\n']"
